AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 18021477 — intervention group
Group type: EXPERIMENTAL
Intervention: Taxanes added to anthracycline-based schedule (either concomitantly or sequentially)
Number of subjects: 9
Study 18021477 — intervention group
Group type: EXPERIMENTAL
Intervention: Taxanes in both treatment arms
Number of subjects: 9
Study 15285157 — intervention group
Group type: EXPERIMENTAL
Intervention: PET (Positron Emission Tomography)
Number of subjects: 0
Study 15285157 — intervention group
Group type: EXPERIMENTAL
Intervention: PET
Number of subjects: 0
Study 15285157 — intervention group
Group type: EXPERIMENTAL
Intervention: PET combined with CT
Number of subjects: 0
Study 11384639 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal progesterone started on the day of oocyte retrieval (group A, n = 43)
Number of subjects: 84
Study 11384639 — intervention group
Group type: COMPARATOR
Intervention: Vaginal progesterone started on the evening of ET (group B, n = 41)
Number of subjects: 84
Study 9279224 — intervention group
Group type: EXPERIMENTAL
Intervention: T-tube system
Number of subjects: 484
Study 9279224 — intervention group
Group type: COMPARATOR
Intervention: Pressure support ventilation of 7 cm H2O
Number of subjects: 484
Study 9279224 — intervention group
Group type: EXPERIMENTAL
Intervention: Reintubated patients
Number of subjects: 484
Study 9279224 — intervention group
Group type: COMPARATOR
Intervention: Successfully extubated patients
Number of subjects: 484
Study 8346490 — intervention group
Group type: EXPERIMENTAL
Intervention: Formoterol 12 micrograms
Number of subjects: 15
Study 8346490 — intervention group
Group type: EXPERIMENTAL
Intervention: Formoterol 24 micrograms
Number of subjects: 15
Study 8346490 — intervention group
Group type: COMPARATOR
Intervention: Salbutamol 400 micrograms
Number of subjects: 15
Study 8346490 — intervention group
Group type: EXPERIMENTAL
Intervention: Formoterol 6 micrograms
Number of subjects: 15
Study 3016080 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical human fibroblast interferon
Number of subjects: 34
Study 3016080 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study 31516094 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics + sertraline (PS)
Number of subjects: 48
Study 31516094 — intervention group
Group type: COMPARATOR
Intervention: Sertraline alone (S)
Number of subjects: 48
Study 31806719 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualised treatment targeting treatable traits
Number of subjects: 55
Study 31806719 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 55
Study 30197271 — intervention group
Group type: EXPERIMENTAL
Intervention: Early enteral nutrition at 3 hours post-PEG placement (group 1)
Number of subjects: 97
Study 30197271 — intervention group
Group type: COMPARATOR
Intervention: Delayed enteral nutrition at 8 hours post-PEG placement (group 2)
Number of subjects: 97
Study 30197271 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 97
Study 28763875 — intervention group
Group type: EXPERIMENTAL
Intervention: Nattokinase (NK) at a daily dose of 6000 FU for 26 weeks
Number of subjects: 82
Study 28763875 — intervention group
Group type: COMPARATOR
Intervention: Statin (simvastatin 20 mg) daily for 26 weeks
Number of subjects: 82
Study 26268133 — intervention group
Group type: EXPERIMENTAL
Intervention: 2h abbreviated fasting with oral ingestion of a carbohydrate and protein solution
Number of subjects: 38
Study 26268133 — intervention group
Group type: COMPARATOR
Intervention: Conventional fasting
Number of subjects: 38
Study 24072755 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision aid plus usual care
Number of subjects: 80
Study 24072755 — intervention group
Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 80
Study 21732797 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin bolus-patch
Number of subjects: 38
Study 20146874 — intervention group
Group type: EXPERIMENTAL
Intervention: Total intravenous anaesthesia (TIVA) with propofol and remifentanil
Number of subjects: 40
Study 20146874 — intervention group
Group type: COMPARATOR
Intervention: Volatile induction and maintenance of anaesthesia (VIMA) with sevoflurane
Number of subjects: 40
Study 16980833 — intervention group
Group type: EXPERIMENTAL
Intervention: Transtheoretical Model (TTM) intervention to increase use of HPDs
Number of subjects: 1245
Study 16980833 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 1245
Study 15151689 — intervention group
Group type: EXPERIMENTAL
Intervention: PRO-SELF: Candidiasis intervention program
Number of subjects: 35
Study 15151689 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 35
Study 15151689 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (PRO-SELF: Candidiasis)
Number of subjects: 35
Study 10868638 — intervention group
Group type: EXPERIMENTAL
Intervention: Quadruple induction therapy (tacrolimus, azathioprine, ALG Merieux, and prednisolone)
Number of subjects: 120
Study 10868638 — intervention group
Group type: COMPARATOR
Intervention: Dual induction therapy (tacrolimus and prednisolone)
Number of subjects: 120
Study 10868638 — intervention group
Group type: EXPERIMENTAL
Intervention: Quadruple induction therapy
Number of subjects: 120
Study 10868638 — intervention group
Group type: COMPARATOR
Intervention: Dual induction therapy
Number of subjects: 120
Study 9171470 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen (HBO2)
Number of subjects: 14
Study 9171470 — intervention group
Group type: COMPARATOR
Intervention: Environmental air (placebo)
Number of subjects: 14
Study 8218538 — intervention group
Group type: EXPERIMENTAL
Intervention: rhIL-3 (0.25, 1.0, 2.5, 5.0, and 10.0 micrograms/kg/day)
Number of subjects: 21
Study 8218538 — intervention group
Group type: EXPERIMENTAL
Intervention: rhIL-3 (10 micrograms/kg/day)
Number of subjects: 21
Study 8218538 — intervention group
Group type: EXPERIMENTAL
Intervention: rhIL-3 (highest dose levels)
Number of subjects: 21
Study 8218538 — intervention group
Group type: EXPERIMENTAL
Intervention: rhIL-3
Number of subjects: 21
Study 3957502 — intervention group
Group type: EXPERIMENTAL
Intervention: Flunarizine 20 mg/per os/day for 14 days, followed by 10 mg/per os/day up to 120 days
Number of subjects: 30
Study 3957502 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 3957502 — intervention group
Group type: EXPERIMENTAL
Intervention: Flunarizine
Number of subjects: 30
Study 2454374 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol i.v. (15 mg)
Number of subjects: 24
Study 2454374 — intervention group
Group type: COMPARATOR
Intervention: Labetalol i.v. (40 mg and 80 mg)
Number of subjects: 24
Study 2454374 — intervention group
Group type: COMPARATOR
Intervention: Saline (control group)
Number of subjects: 24
Study 31554874 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin injection (group A with 13 cases)
Number of subjects: 29
Study 31554874 — intervention group
Group type: COMPARATOR
Intervention: Surgery (group B with 16 cases)
Number of subjects: 29
Study 31554874 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin injection (group A)
Number of subjects: 29
Study 31554874 — intervention group
Group type: COMPARATOR
Intervention: Surgery (group B)
Number of subjects: 29
Study 28170094 — intervention group
Group type: EXPERIMENTAL
Intervention: Freeze-dried amnion graft
Number of subjects: 88
Study 28170094 — intervention group
Group type: COMPARATOR
Intervention: Control (no graft)
Number of subjects: 88
Study 25738668 — intervention group
Group type: EXPERIMENTAL
Intervention: Goserelin with standard chemotherapy
Number of subjects: 257
Study 25738668 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 257
Study 23385648 — intervention group
Group type: EXPERIMENTAL
Intervention: Bisoprolol (5 mg, titrated to 10 mg)
Number of subjects: 209
Study 23385648 — intervention group
Group type: COMPARATOR
Intervention: Atenolol (50 mg, titrated to 100 mg)
Number of subjects: 209
Study 23385648 — intervention group
Group type: COMPARATOR
Intervention: Comparison of bisoprolol and atenolol
Number of subjects: 209
Study 21561817 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based (MB) ME
Number of subjects: 168
Study 21561817 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonjudgmental (NJ) ME
Number of subjects: 168
Study 21561817 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive dissonance-based (CD) ME
Number of subjects: 168
Study 21561817 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 168
Study 19226293 — intervention group
Group type: EXPERIMENTAL
Intervention: Laryngeal Mask Airway (LMA)
Number of subjects: 134
Study 19226293 — intervention group
Group type: COMPARATOR
Intervention: Orotracheal Intubation
Number of subjects: 134
Study 16808741 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine gum plus health education (HE) counseling
Number of subjects: 0
Study 16808741 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine gum plus motivational interviewing (MI) counseling
Number of subjects: 0
Study 16808741 — intervention group
Group type: COMPARATOR
Intervention: Placebo gum plus HE counseling
Number of subjects: 0
Study 16808741 — intervention group
Group type: COMPARATOR
Intervention: Placebo gum plus MI counseling
Number of subjects: 0
Study 12602466 — intervention group
Group type: EXPERIMENTAL
Intervention: FX 60 dialyzer
Number of subjects: 8
Study 12602466 — intervention group
Group type: COMPARATOR
Intervention: F 60S dialyzer
Number of subjects: 8
Study 11469617 — intervention group
Group type: EXPERIMENTAL
Intervention: Vacuum-lancet device applied to the forearm
Number of subjects: 215
Study 11469617 — intervention group
Group type: EXPERIMENTAL
Intervention: Vacuum-lancet device
Number of subjects: 215
Study 9519505 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine GITS
Number of subjects: 99
Study 9519505 — intervention group
Group type: COMPARATOR
Intervention: Diltiazem
Number of subjects: 99
Study 8229434 — intervention group
Group type: EXPERIMENTAL
Intervention: 70% isopropyl alcohol
Number of subjects: 0
Study 8229434 — intervention group
Group type: EXPERIMENTAL
Intervention: povidone-iodine
Number of subjects: 0
Study 8229434 — intervention group
Group type: COMPARATOR
Intervention: Control group (no scrub)
Number of subjects: 0
Study 3956833 — intervention group
Group type: EXPERIMENTAL
Intervention: Subtotal hysterectomy
Number of subjects: 22
Study 3956833 — intervention group
Group type: EXPERIMENTAL
Intervention: Total hysterectomy
Number of subjects: 22
Study 31779987 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified alternate-day fasting diet
Number of subjects: 70
Study 31779987 — intervention group
Group type: COMPARATOR
Intervention: Calorie restriction
Number of subjects: 70
Study 26618715 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 mg GOE
Number of subjects: 0
Study 26618715 — intervention group
Group type: EXPERIMENTAL
Intervention: 1600 mg GOE
Number of subjects: 0
Study 26618715 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 26033058 — intervention group
Group type: EXPERIMENTAL
Intervention: All-polyethylene component
Number of subjects: 45
Study 26033058 — intervention group
Group type: COMPARATOR
Intervention: Metal-backed component
Number of subjects: 45
Study 23901839 — intervention group
Group type: EXPERIMENTAL
Intervention: IVIG + infliximab
Number of subjects: 14
Study 23901839 — intervention group
Group type: COMPARATOR
Intervention: IVIG
Number of subjects: 14
Study 21592143 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction procedure using traits as OS categories
Number of subjects: 0
Study 21592143 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction procedure using traits as TS categories
Number of subjects: 0
Study 21592143 — intervention group
Group type: COMPARATOR
Intervention: Control condition (no practice of traits)
Number of subjects: 0
Study 19752363 — intervention group
Group type: EXPERIMENTAL
Intervention: 5g IV MgSO(4) followed by daily 4-hour infusions from postoperative day 1 until postoperative day 4
Number of subjects: 927
Study 19752363 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 927
Study 17562640 — intervention group
Group type: EXPERIMENTAL
Intervention: Attentional Focus and Symptom Management Intervention (AFSMI) during two phone sessions, at 3-4 days and 10-11 days after surgery
Number of subjects: 117
Study 17562640 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 117
Study 15083478 — intervention group
Group type: EXPERIMENTAL
Intervention: Methods allowing for uncertainty in intracluster correlation coefficient (ICC)
Number of subjects: 0
Study 15083478 — intervention group
Group type: EXPERIMENTAL
Intervention: Methods allowing for uncertainty in ICC
Number of subjects: 0
Study 12093851 — intervention group
Group type: EXPERIMENTAL
Intervention: Day 3 embryo transfer
Number of subjects: 0
Study 12093851 — intervention group
Group type: COMPARATOR
Intervention: Day 5 embryo transfer
Number of subjects: 0
Study 12093851 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryopreserved embryo transfers
Number of subjects: 0
Study 9670257 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative radiotherapy
Number of subjects: 0
Study 9670257 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 0
Study 9670257 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative radiotherapy
Number of subjects: 0
Study 9670257 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative irradiation
Number of subjects: 0
Study 7874899 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.50 mL normal saline injection
Number of subjects: 34
Study 7874899 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.75 mL normal saline injection
Number of subjects: 34
Study 7874899 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mL normal saline injection
Number of subjects: 34
Study 7874899 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25 mL normal saline injection
Number of subjects: 34
Study 7874899 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal saline injections (all volumes)
Number of subjects: 34
Study 7874899 — intervention group
Group type: COMPARATOR
Intervention: Control groups (nonintubated patients)
Number of subjects: 34
Study 1699907 — intervention group
Group type: EXPERIMENTAL
Intervention: Raveron
Number of subjects: 30
Study 1699907 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 763213 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular injection of 250 mg of lidocaine in a 10% solution into the deltoid muscle
Number of subjects: 10
Study 763213 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular injection of 250 mg of lidocaine in a 10% solution into the lateral vastus muscle
Number of subjects: 10
Study 31973596 — intervention group
Group type: EXPERIMENTAL
Intervention: Ad-SGE-REIC
Number of subjects: 0
Study 31503180 — intervention group
Group type: EXPERIMENTAL
Intervention: Paranoid ideation without psychosis (PIP)
Number of subjects: 12532
Study 31503180 — intervention group
Group type: EXPERIMENTAL
Intervention: PIP symptoms (specifically 'spouse was being unfaithful')
Number of subjects: 12532
Study 31503180 — intervention group
Group type: EXPERIMENTAL
Intervention: PIP in combination with major depressive disorder (MDD)
Number of subjects: 12532
Study 31503180 — intervention group
Group type: EXPERIMENTAL
Intervention: PIP (specifically 'doubting spouse')
Number of subjects: 12532
Study 29050954 — intervention group
Group type: EXPERIMENTAL
Intervention: Transarterial chemoembolization (TACE)
Number of subjects: 20
Study 29050954 — intervention group
Group type: EXPERIMENTAL
Intervention: Stereotactic body radiation therapy (SBRT) with a target dose of 48-54 Gy in six fractions
Number of subjects: 20
Study 29050954 — intervention group
Group type: COMPARATOR
Intervention: Co-planar autoVMAT QA plans
Number of subjects: 20
Study 25562685 — intervention group
Group type: EXPERIMENTAL
Intervention: Paliperidone monthly
Number of subjects: 334
Study 25562685 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 334
Study 22431145 — intervention group
Group type: EXPERIMENTAL
Intervention: VPT/CEM (Vital Pulp Therapy with Calcium-Enriched Mixture Cement)
Number of subjects: 407
Study 22431145 — intervention group
Group type: COMPARATOR
Intervention: RCT (Root Canal Therapy)
Number of subjects: 407
Study 21484362 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle training (PFMT)
Number of subjects: 37
Study 21484362 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 37
Study 19530584 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural nalbuphine 5 mg
Number of subjects: 182
Study 19530584 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural nalbuphine 10 mg
Number of subjects: 182
Study 19530584 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 182
Study 19530584 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 182
Study 18217833 — intervention group
Group type: EXPERIMENTAL
Intervention: Training on visual letter recognition strings
Number of subjects: 0
Study 18217833 — intervention group
Group type: COMPARATOR
Intervention: No training
Number of subjects: 0
Study 18217833 — intervention group
Group type: EXPERIMENTAL
Intervention: Short amount of training
Number of subjects: 0
Study 18217833 — intervention group
Group type: EXPERIMENTAL
Intervention: Further training
Number of subjects: 0
Study 18217833 — intervention group
Group type: EXPERIMENTAL
Intervention: Using words as stimuli
Number of subjects: 0
Study 15302721 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal Proportional Assist Ventilation (PAV)
Number of subjects: 14
Study 15302721 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure Support Ventilation (PSV)
Number of subjects: 14
Study 11559309 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous apomorphine hydrochloride (2-10 mg, n = 20)
Number of subjects: 29
Study 11559309 — intervention group
Group type: COMPARATOR
Intervention: pH-matched vehicle placebo (n = 9)
Number of subjects: 29
Study 11559309 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous apomorphine hydrochloride (2-10 mg)
Number of subjects: 29
Study 11559309 — intervention group
Group type: COMPARATOR
Intervention: pH-matched vehicle placebo
Number of subjects: 29
Study 9733667 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral ifosfamide with methylene blue (50 mg po 3 times daily)
Number of subjects: 9
Study 9733667 — intervention group
Group type: COMPARATOR
Intervention: Intravenous ifosfamide (one of the first two cycles)
Number of subjects: 9
Study 9733667 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylene blue administration
Number of subjects: 9
Study 9733667 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall alkylating activity in urine
Number of subjects: 9
Study 7798164 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid transfusion of RBC by apheresis
Number of subjects: 9
Study 3184889 — intervention group
Group type: EXPERIMENTAL
Intervention: Cocaine 15 mg
Number of subjects: 5
Study 3184889 — intervention group
Group type: EXPERIMENTAL
Intervention: Cocaine 40 mg
Number of subjects: 5
Study 3184889 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study 3184889 — intervention group
Group type: EXPERIMENTAL
Intervention: Cocaine (15 mg and 40 mg combined)
Number of subjects: 5
Study 31995194 — intervention group
Group type: COMPARATOR
Intervention: Household ambulators
Number of subjects: 252
Study 31995194 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximum steps per bout
Number of subjects: 252
Study 31995194 — intervention group
Group type: EXPERIMENTAL
Intervention: Bouts per day
Number of subjects: 252
Study 30097164 — intervention group
Group type: EXPERIMENTAL
Intervention: Spironolactone (non-selective MRA)
Number of subjects: 62
Study 30097164 — intervention group
Group type: EXPERIMENTAL
Intervention: Eplerenone (selective MRA)
Number of subjects: 62
Study 28659251 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based alcohol intervention
Number of subjects: 898
Study 25163819 — intervention group
Group type: EXPERIMENTAL
Intervention: 17OHPC (250 mg weekly injections)
Number of subjects: 288
Study 25163819 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 288
Study 23303045 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram
Number of subjects: 24
Study 23303045 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute Tryptophan Depletion
Number of subjects: 24
Study 23303045 — intervention group
Group type: COMPARATOR
Intervention: Control Trials
Number of subjects: 24
Study 21156272 — intervention group
Group type: EXPERIMENTAL
Intervention: ABT-089 (0.085-0.700 mg/kg, once daily)
Number of subjects: 393
Study 21156272 — intervention group
Group type: EXPERIMENTAL
Intervention: ABT-089 (0.7 mg/kg, 1.4 mg/kg, once daily)
Number of subjects: 393
Study 21156272 — intervention group
Group type: EXPERIMENTAL
Intervention: Atomoxetine (QD)
Number of subjects: 393
Study 21156272 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 393
Study 18651341 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomethiazole
Number of subjects: 168
Study 18651341 — intervention group
Group type: COMPARATOR
Intervention: Carbamazepine
Number of subjects: 168
Study 16518962 — intervention group
Group type: COMPARATOR
Intervention: Triple therapy (zidovudine/lamivudine/efavirenz)
Number of subjects: 114
Study 16518962 — intervention group
Group type: EXPERIMENTAL
Intervention: Quadruple therapy (abacavir/lamivudine/zidovudine/tenofovir)
Number of subjects: 114
Study 14734394 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate (1mEq/l) administration
Number of subjects: 874
Study 14734394 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific antiarrhythmic use
Number of subjects: 874
Study 14734394 — intervention group
Group type: COMPARATOR
Intervention: Historical factors (chief complaint, medical history, specific disease conditions, overall drug use)
Number of subjects: 874
Study 10966362 — intervention group
Group type: EXPERIMENTAL
Intervention: First metatarsal osteotomies
Number of subjects: 114
Study 10966362 — intervention group
Group type: COMPARATOR
Intervention: Hallux valgus foot
Number of subjects: 114
Study 10966362 — intervention group
Group type: COMPARATOR
Intervention: Hallux valgus foot with overlap toes
Number of subjects: 114
Study 9341056 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional fixed pressure CPAP (group 1)
Number of subjects: 36
Study 9341056 — intervention group
Group type: EXPERIMENTAL
Intervention: Automatic CPAP at measured reference pressure (group 2)
Number of subjects: 36